Ken Griffin Thermo Fisher Scientific Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$528.82 - $599.43 $106 Million - $120 Million	-200,800 Reduced 45.75%	238,100 $138 Million
Q4 2023 Feb 14, 2024	SELL	$431.41 - $532.94 $13.5 Million - $16.7 Million	-31,400 Reduced 6.68%	438,900 $233 Million
Q3 2023 Nov 14, 2023	SELL	$498.29 - $574.41 $45.4 Million - $52.3 Million	-91,100 Reduced 16.23%	470,300 $238 Million
Q2 2023 Aug 14, 2023	BUY	$508.46 - $591.13 $70 Million - $81.3 Million	137,600 Added 32.47%	561,400 $293 Million
Q1 2023 May 15, 2023	BUY	$535.0 - $604.82 $1.07 Million - $1.21 Million	2,000 Added 0.47%	423,800 $244 Million

Q4 2022 Feb 14, 2023	SELL	$484.71 - $571.37 $197 Million - $232 Million	-406,200 Reduced 49.06%	421,800 $232 Million
Q3 2022 Nov 14, 2022	BUY	$507.19 - $604.49 $244 Million - $290 Million	480,100 Added 138.0%	828,000 $420 Million

2,722

331M

1.58M

2.01M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $218B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.